# A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents

> **NCT01843491** · PHASE1 · WITHDRAWN · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Healthy
- Malaria

## Interventions

- **BIOLOGICAL:** Ad-PfCA

## Key facts

- **NCT ID:** NCT01843491
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not go forward with study.
- **Last updated:** 2015-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01843491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01843491, "A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01843491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*